Literature DB >> 10695599

Bias in breast cancer analyses due to error in age at menopause.

B Rockhill1, G A Colditz, B Rosner.   

Abstract

With the use of data from the Nurses' Health Study, the authors confirm the recent argument by Pike et al. (Am J Epidemiol 1998;147:718-21) that various ways of assigning ages at menopause to women with simple hysterectomy produce relative risks for the effect of hormone replacement therapy (HRT) that are biased downward. Different methods of including women with simple hysterectomy consistently produced relative risks for the association between a 1-year increase in duration of HRT use and breast cancer that were underestimates compared with the relative risk obtained when these women were excluded from analysis. The authors used longitudinal data on recalled age at menopause to demonstrate another source of error related to age at menopause: error in recall of age at menopause that increases with time since menopause.

Entities:  

Mesh:

Year:  2000        PMID: 10695599     DOI: 10.1093/oxfordjournals.aje.a010220

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life.

Authors:  Marie Søfteland Sandvei; Lars J Vatten; Elisabeth Krefting Bjelland; Anne Eskild; Solveig Hofvind; Giske Ursin; Signe Opdahl
Journal:  Eur J Epidemiol       Date:  2018-08-06       Impact factor: 8.082

2.  Age at menopause: imputing age at menopause for women with a hysterectomy with application to risk of postmenopausal breast cancer.

Authors:  Bernard Rosner; Graham A Colditz
Journal:  Ann Epidemiol       Date:  2011-03-26       Impact factor: 3.797

3.  Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.

Authors:  Tanmai Saxena; Eunjung Lee; Katherine D Henderson; Christina A Clarke; Dee West; Sarah F Marshall; Dennis Deapen; Leslie Bernstein; Giske Ursin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-10       Impact factor: 4.254

4.  Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Melissa Wellons; Pamela Ouyang; Pamela J Schreiner; David M Herrington; Dhananjay Vaidya
Journal:  Menopause       Date:  2012-10       Impact factor: 2.953

5.  Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort.

Authors:  Louise A Brinton; Douglas Richesson; Michael F Leitzmann; Gretchen L Gierach; Arthur Schatzkin; Traci Mouw; Albert R Hollenbeck; James V Lacey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

6.  Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.

Authors:  Christine G Parks; Frederick W Miller; Minoru Satoh; Edward K L Chan; Zhanna Andrushchenko; Linda S Birnbaum; Todd A Jusko; Grace E Kissling; Mehul D Patel; Kathryn M Rose; Clarice Weinberg; Darryl C Zeldin; Dale P Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-01       Impact factor: 4.254

7.  Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Authors:  Agnès Fournier; Alban Fabre; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Franco Berrino; Françoise Clavel-Chapelon
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

8.  Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting.

Authors:  Amanda I Phipps; Diana S M Buist
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

9.  Breast cancer risk and hysterectomy status: the Multiethnic Cohort study.

Authors:  Christy G Woolcott; Gertraud Maskarinec; Malcolm C Pike; Brian E Henderson; Lynne R Wilkens; Laurence N Kolonel
Journal:  Cancer Causes Control       Date:  2008-11-14       Impact factor: 2.506

10.  Predictors and risk model development for menopausal age in fragile X premutation carriers.

Authors:  Marian A Spath; Ton B Feuth; Arie P T Smits; Helger G Yntema; Didi D M Braat; Chris M G Thomas; Ad Geurts van Kessel; Stephanie L Sherman; Emily G Allen
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.